TABLE 1.
Descriptive characteristics of study participants1
Variable | Mean ± SD | Median [IQR] |
---|---|---|
Sex, n (M/F) | 279/723 | |
Age, y | 45.6 ± 11.9 | 46.98 [37.57–54.34] |
Weight, kg | 72.88 ± 15.27 | 70.28 [61.90–81.30] |
Height, cm | 168.53 ± 10.51 | 167.60 [162.30–174.00] |
BMI, kg/m2 | 25.59 ± 5.02 | 24.58 [22.29–27.87] |
Waist circumference, cm | 85.86 ± 12.93 | 85.00 [76.00–93.50] |
Hip circumference, cm | 101.60 ± 10.54 | 100.00 [95.00–107.00] |
Waist-to-hip ratio | 0.84 ± 0.08 | 0.84 [0.79–0.90] |
Diastolic pulse, mm Hg | 75.78 ± 10.14 | 75.50 [69.00–82.00] |
Systolic pulse, mm Hg | 124.26 ± 14.58 | 123.00 [114.50–132.75] |
Alanine aminotransferase, U/L | 23.24 ± 11.57 | 20.40 [16.40–26.08] |
Total cholesterol, mmol/L | 4.94 ± 0.98 | 4.87 [4.29–5.55] |
HDL cholesterol, mmol/L | 1.62 ± 0.41 | 1.59 [1.32–1.87] |
LDL cholesterol, mmol/L | 3.07 ± 0.96 | 2.97 [2.35–3.67] |
Non-HDL cholesterol, mmol/L | 3.28 ± 1.00 | 3.17 [2.52–3.90] |
Total cholesterol:HDL cholesterol ratio | 3.21 ± 0.95 | 3.06 [2.49–3.69] |
Insulin, mU/L | 6.13 ± 4.27 | 5.22 [3.62–7.40] |
C-peptide, μg/L | 1.19 ± 0.51 | 1.07 [0.85–1.40] |
HbA1c, % | 5.47 ± 0.28 | 5.50 [5.30–5.70] |
1n = 1002. HbA1c, glycated hemoglobin.